FindTrial
Sign In

Effect of Menstrugole capsule and Zintoma capsule versus Mefenamic Acid capsule on postpartum pains

Effect of Menstrugole capsule and Zintoma capsule versus Mefenamic Acid capsule on postpartum pains in multiparous women: a double-blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120215009014N545
Enrollment
135
Registered
2024-12-12
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum pains. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group 1: Menstrugel capsule (containing dried celery, saffron, anise extract powder) 80 mg, manufactured by Gol Daru Company, 2 hours after delivery, every 6 hours, 4 caps

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 44 Years

Inclusion criteria

Inclusion criteria: Age 15 to 44 years Second pregnancy and beyond Singleton vaginal delivery 37 to 42 weeks gestation Birth weight between 2500 and 4000 grams

Exclusion criteria

Exclusion criteria: Rapture grade 3 to 4 Previous cesarean section or abdominal surgery Use of epidural or spinal anesthesia during labor

Design outcomes

Primary

MeasureTime frame
Average postpartum pain score. Timepoint: Before intervention and 24 hours later. Method of measurement: Using Visual Analog Scale (VAS).—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahimeh Ezzati Arasateh

Hamedan University of Medical Sciences

fezzati1992@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026